Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Mersana Therapeutics, Inc. (MRSN)  
$0.40 0.00 (-0.58%) as of 4:30 Fri 5/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 120,580,000
Market Cap: 47.95(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2614 - $3.525
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. Co.'s platforms including Dolaflexin and Dolasynthen, deliver its auristatin DolaLock payload, as well as Immunosynthen, which delivers its stimulator of interferon genes (STING) agonist ImmunoLock payload. Co.'s product candidates include: upifitamab rilsodotin (UpRi), which is a Dolaflexin ADC targeting NaPi2b, an antigen expressed in ovarian cancer and other cancers; and XMT-1592, which is a Dolasynthen ADC targeting NaPi2b-expressing tumor cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 83,637 198,908 268,057
Total Sell Value $0 $51,269 $268,491 $449,944
Total People Sold 0 7 7 8
Total Sell Transactions 0 18 30 39
End Date 2025-02-02 2024-11-01 2024-05-03 2023-05-04

   
Records found: 302
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Huber Martin H. Jr. President, CEO   •       •      –    2025-01-16 4 AS $0.58 $2,618 D/D (4,514) 122,875 -35%     
   Bala Mohan SVP, Chief Development Officer   •       –      –    2025-01-16 4 AS $0.58 $3,445 D/D (5,939) 68,872 -35%     
   Deschuytner Brian SVP, COO & CFO   •       –      –    2025-01-16 4 AS $0.58 $4,913 D/D (8,470) 121,393 -35%     
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2025-01-16 4 AS $0.58 $4,668 D/D (8,048) 257,673 -35%     
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2025-01-16 4 AS $0.58 $2,956 D/D (5,096) 78,296 -35%     
   Protopapas Anna Director   –       •      –    2025-01-16 4 AS $0.58 $5,009 D/D (8,637) 168,041 -35%     
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2025-01-16 4 AS $0.58 $2,061 D/D (3,554) 57,519 -35%     
   Huber Martin H. Jr. President, CEO   •       •      –    2025-01-15 4 OE $0.00 $0 D/D 11,062 127,389     -
   Bala Mohan SVP, Chief Development Officer   •       –      –    2025-01-15 4 OE $0.00 $0 D/D 14,583 74,811     -
   Deschuytner Brian SVP, COO & CFO   •       –      –    2025-01-15 4 OE $0.00 $0 D/D 20,833 129,863     -
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2025-01-15 4 OE $0.00 $0 D/D 19,791 265,721     -
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2025-01-15 4 OE $0.00 $0 D/D 12,500 83,392     -
   Protopapas Anna Director   –       •      –    2025-01-15 4 OE $0.00 $0 D/D 21,250 176,678     -
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2025-01-15 4 OE $0.00 $0 D/D 8,685 61,073     -
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2025-01-15 4 AS $0.63 $600 D/D (952) 70,892 -38%     
   Deschuytner Brian SVP, COO & CFO   •       –      –    2025-01-15 4 AS $0.63 $1,469 D/D (2,331) 109,030 -38%     
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2025-01-15 4 AS $0.63 $1,130 D/D (1,794) 245,930 -38%     
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2025-01-15 4 AS $0.63 $1,128 D/D (1,791) 52,388 -38%     
   Protopapas Anna Director   –       •      –    2025-01-15 4 AS $0.63 $3,900 D/D (6,191) 155,428 -38%     
   Carvajal Alejandra SVP, Chief Legal Officer   •       –      –    2025-01-14 4 OE $0.00 $0 D/D 2,500 71,844     -
   Deschuytner Brian SVP, COO & CFO   •       –      –    2025-01-14 4 OE $0.00 $0 D/D 6,250 111,361     -
   Lowinger Timothy B SVP, Chief Sci.&Tech. Officer   •       –      –    2025-01-14 4 OE $0.00 $0 D/D 4,792 247,724     -
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2025-01-14 4 OE $0.00 $0 D/D 4,783 54,179     -
   Protopapas Anna Director   –       •      –    2025-01-14 4 OE $0.00 $0 D/D 16,750 161,619     -
   Mandelia Ashish VP, Chief Accounting Officer   •       –      –    2025-01-14 4 AS $0.66 $665 D/D (1,007) 49,396 -37%     
  302 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us